Transplant Immunology Unit, Microbiology National Center, Instituto de Salud Carlos III, Madrid, Spain; Microbiology Section, Department of Pharmaceutical Science and Health, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, Boadilla del Monte, Spain; Departamento de Ciencias Médicas Básicas, Instituto de Medicina Molecular Aplicada (IMMA) Nemesio Díez, Facultad de Medicina, Universidad San Pablo-CEU, CEU Universities, Boadilla del Monte, Spain.
Independent researcher, Madrid, Spain.
Int J Infect Dis. 2023 Jun;131:173-179. doi: 10.1016/j.ijid.2023.04.003. Epub 2023 Apr 7.
The clinical burden of influenza is increasing worldwide. Aging, immunosuppression, and underlying respiratory illness are determinants of poor clinical outcomes, including greater mortality. Bacterial infections seem to be the main reason. Updated information on the role of bacterial infection as the cause of complications would be of value in improving the prognosis of patients with influenza.
A systematic review and meta-analysis were performed by using the PubMed repository using keywords like: Influenza, H1N1, Streptococcus pneumoniae, bacterial coinfection, secondary coinfection, bacterial complications in pneumonia, and seasonal influenza. Only articles written in English were included in publications from 2010 to 2020. The analyses were conducted following the preferred reporting items for systematic review and meta-analyses guidelines. The results were independently validated using a TrinetX database cohort of roughly 4 million patients.
We included 135 studies that contained data from 48,259 patients hospitalized with influenza of any age. Bacterial infections were diagnosed in 5391 (11.2%). Streptococcus pneumoniae (30.7%) and Staphylococcus aureus (30.4%) were the most frequent microorganisms, followed by Haemophilus influenzae (7.1%) and Pseudomonas aeruginosa (5.9%). The random-effects model of the meta-analysis indicated that bacterial infections posed a 3.4-fold increased risk of death compared with influenza infection alone. Unexpectedly, asthma was protective (odds ratio 0.8).
Bacterial infections diagnosed in 11.2% of patients with influenza increase 3.4-fold the mortality risk. S. pneumoniae, S. aureus, H. influenzae, and P. aeruginosa account for nearly 75% of the cases. Earlier diagnosis and use of antibiotics should improve outcomes in this population.
流感在全球的临床负担正在增加。老龄化、免疫抑制和潜在的呼吸道疾病是导致不良临床结局的决定因素,包括更高的死亡率。细菌感染似乎是主要原因。了解细菌感染作为并发症的原因的最新信息,对于改善流感患者的预后将具有重要价值。
使用 PubMed 数据库,通过关键词(如:流感、H1N1、肺炎链球菌、细菌合并感染、二次合并感染、肺炎细菌并发症、季节性流感)进行系统回顾和荟萃分析。只纳入了 2010 年至 2020 年期间发表的英文文章。分析结果遵循系统评价和荟萃分析报告的首选条目进行。使用 TrinetX 数据库的近 400 万患者队列对结果进行了独立验证。
我们纳入了 135 项研究,其中包含了来自 48259 名任何年龄因流感住院的患者的数据。在这些患者中,诊断出细菌感染的有 5391 例(11.2%)。肺炎链球菌(30.7%)和金黄色葡萄球菌(30.4%)是最常见的微生物,其次是流感嗜血杆菌(7.1%)和铜绿假单胞菌(5.9%)。荟萃分析的随机效应模型表明,与单纯流感感染相比,细菌感染导致死亡的风险增加了 3.4 倍。出乎意料的是,哮喘具有保护作用(比值比 0.8)。
在流感患者中,诊断出的细菌感染使死亡率风险增加了 3.4 倍。肺炎链球菌、金黄色葡萄球菌、流感嗜血杆菌和铜绿假单胞菌占病例的近 75%。早期诊断和使用抗生素应该可以改善这部分人群的结局。